Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Other Liabilities

Gilead Sciences Inc Other Liabilities Chart (GILD)

Gilead Sciences Inc annual/quarterly Other Liabilities from 2010 to 2020.
  • Gilead Sciences Inc Other Liabilities for the quarter ending June 06, 2020 was $6,125m a -0.15% decrease of -9m year over year
  • Gilead Sciences Inc Other Liabilities for the last 12 months ending June 06, 2020 was $6,125m a -0.15% decrease of -9m year over year
  • Gilead Sciences Inc Annual Other Liabilities for 2019 was $6,498m a -7.14% decrease of -464m from 2018
  • Gilead Sciences Inc Annual Other Liabilities for 2018 was $6,962m a -5.60% decrease of -390m from 2017
  • Gilead Sciences Inc Annual Other Liabilities for 2017 was $7,352m a 72.12% increase of 5,302m from 2016
Other Balance Sheet Metrics:
  • Gilead Sciences Inc Total Assets for the quarter ending December 12, 2018 was $63,675m a -2.68% decrease of -1,706m year over year
  • Gilead Sciences Inc Total Equity for the quarter ending December 12, 2018 was $21,534m a 4.10% increase of 883m year over year
View Chart On Koyfin

Quarterly GILD Other Liabilities Data

06/2020$6,125m
03/2020$6,585m
12/2019$6,498m
09/2019$6,134m
06/2019$6,933m
03/2019$6,840m
12/2018$6,962m
09/2018$6,612m
06/2018$6,647m
03/2018$7,503m

Annual GILD Other Liabilities Data

2019$6,498m
2018$6,962m
2017$7,352m
2016$2,050m
2015$1,638m
2014$1,148m
2013$424m
2012$397m
2011$315m
2010$167m